Observational study analyzes glucocorticoids impact on inflammation and treatment response in cerebral venous thrombosis, indicating potential benefits.
Neutrophils, hs-CRP, and IL-6 are promising biomarkers for CVT severity and treatment response. Glucocorticoids may improve outcomes by modulating inflammation, warranting further research into their mechanisms and long-term efficacy in CVT management.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: